SK278944B6 - Farmaceutický prípravok - Google Patents

Farmaceutický prípravok Download PDF

Info

Publication number
SK278944B6
SK278944B6 SK2326-92A SK232692A SK278944B6 SK 278944 B6 SK278944 B6 SK 278944B6 SK 232692 A SK232692 A SK 232692A SK 278944 B6 SK278944 B6 SK 278944B6
Authority
SK
Slovakia
Prior art keywords
acid
compound
solution
pharmaceutical composition
sulphate
Prior art date
Application number
SK2326-92A
Other languages
English (en)
Slovak (sk)
Other versions
SK232692A3 (en
Inventor
J�Zsef B�Res
J�Zsef B�Res Jr.
Original Assignee
B�Res Export-Import Rt. Of 9
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by B�Res Export-Import Rt. Of 9 filed Critical B�Res Export-Import Rt. Of 9
Publication of SK232692A3 publication Critical patent/SK232692A3/sk
Publication of SK278944B6 publication Critical patent/SK278944B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/32—Manganese; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/34—Copper; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Percussion Or Vibration Massage (AREA)
  • Catching Or Destruction (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
  • Electrotherapy Devices (AREA)
  • Circuits Of Receivers In General (AREA)
SK2326-92A 1991-07-24 1992-07-24 Farmaceutický prípravok SK278944B6 (sk)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU912492A HU207799B (en) 1991-07-24 1991-07-24 Process for producing pharmaceutical composition for influencing the reticuloendothelial system, for treating chronic pain symptomes of degenerative locomotor disorders or tumors, and for treating mucoviscidosis

Publications (2)

Publication Number Publication Date
SK232692A3 SK232692A3 (en) 1995-06-07
SK278944B6 true SK278944B6 (sk) 1998-05-06

Family

ID=10959658

Family Applications (1)

Application Number Title Priority Date Filing Date
SK2326-92A SK278944B6 (sk) 1991-07-24 1992-07-24 Farmaceutický prípravok

Country Status (18)

Country Link
US (2) US5312629A (ko)
EP (1) EP0524633B1 (ko)
JP (1) JP2673852B2 (ko)
KR (1) KR100234855B1 (ko)
AT (1) ATE178213T1 (ko)
BG (1) BG61250B1 (ko)
CA (1) CA2074639C (ko)
CZ (1) CZ281672B6 (ko)
DE (1) DE69228777T2 (ko)
FI (1) FI923364A (ko)
HR (1) HRP920192B1 (ko)
HU (1) HU207799B (ko)
PL (1) PL169684B1 (ko)
RO (1) RO109505B1 (ko)
RU (1) RU2093160C1 (ko)
SI (1) SI9200155A (ko)
SK (1) SK278944B6 (ko)
YU (1) YU48243B (ko)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5871779A (en) * 1994-01-18 1999-02-16 Mount Sinai Hospital Corporation Treatment of arthropathies with vanadate compounds or analogues thereof
US5843481A (en) * 1994-01-18 1998-12-01 Mount Sinai Hospital Corporation Treatment of proliferative disorders, metastasaes, and drug resistant tumors with vanadate compounds and derivatives or analogues thereof
GB9416768D0 (en) * 1994-08-18 1994-10-12 Nycomed Innovation Ab Compositions
US5863519A (en) * 1994-08-18 1999-01-26 Nycomed Imaging As Composition and method of MRI using both a positive and a negative contrast agent
WO1996005867A2 (en) * 1994-08-18 1996-02-29 Nycomed Imaging A/S Compositions
GB9416767D0 (en) * 1994-08-18 1994-10-12 Nycomed Innovation Ab Compositions
FR2740342B1 (fr) * 1995-10-26 1997-12-19 Oreal Utilisation de sel de lanthanide, de manganese, de lithium, d'etain, de zinc ou d'yttrium, de cobalt, de baryum, de strontium dans des compositions pharmaceutiques
RU2146146C1 (ru) * 1999-05-05 2000-03-10 Дубинина Лариса Васильевна Репаративно-регенеративный препарат, способ его изготовления и лечебного использования по л.в.дубининой
US20030170318A1 (en) * 2000-09-29 2003-09-11 Steiner Gregory Gene Fluoride compositions and uses thereof
US6638431B2 (en) * 2001-05-03 2003-10-28 Mainstream Engineering Corporation Formulation and method for treating wetted surface elements in climate control systems
KR20050018250A (ko) * 2003-08-14 2005-02-23 한영주 복합생약 조성물을 함유하는 항암활성을 갖는 조성물
KR100889994B1 (ko) * 2003-08-14 2009-03-24 한영미 녹반을 함유하는 항암활성을 갖는 조성물
US20060134227A1 (en) * 2004-12-22 2006-06-22 Bortz Jonathan D Compositions including iron
WO2006130027A1 (en) * 2005-05-31 2006-12-07 Santos Ma Joyce Bedelia B Aqueous oral liquid vitamin supplements containing stabilized vitamin c and metal ions
WO2006130839A1 (en) * 2005-06-02 2006-12-07 U.S. Borax Inc. Prevention and treatment of osteochondrosis in animals and humans
RU2009125565A (ru) * 2006-12-06 2011-01-20 Ю. Эс. Боракс Инк. (Us) Композиции корма для животных
EP1949894B1 (en) * 2007-01-25 2016-06-29 Roche Diagnostics GmbH Enhancement of vanadium-containing phosphatase inhibitors by polyols
US8008035B2 (en) 2007-01-25 2011-08-30 Roche Diagnostics Operations, Inc. Enhancement of vanadium-containing phosphatase inhibitors
US10634385B2 (en) 2009-09-03 2020-04-28 Ademco Inc. Heat balancing system
CN115927242A (zh) 2012-05-11 2023-04-07 珍白斯凯尔有限公司 具有抗炎活性的肽及其在制备抗炎组合物中的应用
US10967000B2 (en) 2012-07-11 2021-04-06 Gemvax & Kael Co., Ltd. Cell-penetrating peptide, conjugate comprising same and composition comprising same
CN105535931A (zh) 2013-06-07 2016-05-04 凯尔杰姆维克斯有限公司 在癌症免疫疗法中有用的生物标记
TWI539960B (zh) 2013-06-21 2016-07-01 凱爾傑姆維克斯有限公司 激素分泌調節劑、包括其的組成物以及其用途
KR102314231B1 (ko) 2013-12-17 2021-10-19 주식회사 젬백스앤카엘 전립선 암 치료용 조성물
WO2015126265A1 (en) * 2014-02-18 2015-08-27 Santos Joyce Bedelia B Oral liquid vitamin supplements containing zinc and stabilized vitamin c with reduced astringency
CN106456697B (zh) 2014-04-11 2019-12-17 珍白斯凯尔有限公司 具有纤维化抑制活性的肽和含有其的组合物
US10662223B2 (en) 2014-04-30 2020-05-26 Gemvax & Kael Co., Ltd. Composition for organ, tissue, or cell transplantation, kit, and transplantation method
KR102413243B1 (ko) 2014-12-23 2022-06-27 주식회사 젬백스앤카엘 안질환 치료 펩티드 및 이를 포함하는 안질환 치료용 조성물
KR102636129B1 (ko) 2015-02-27 2024-02-14 주식회사 젬백스앤카엘 청력 손상 방어용 펩타이드 및 이를 포함하는 조성물
ES2886946T3 (es) 2015-07-02 2021-12-21 Gemvax & Kael Co Ltd Péptido con efecto antiviral y composición que lo contiene
WO2017176087A1 (ko) 2016-04-07 2017-10-12 주식회사 젬백스앤카엘 텔로머라제 활성 증가 및 텔로미어 연장 효능을 가지는 펩티드 및 이를 포함하는 조성물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2022998B (en) * 1978-06-14 1982-09-08 Beres J Phermaceutical composition for the treatment of neoplasticand other diseases
JPS554348A (en) * 1978-06-26 1980-01-12 Peresu Yozefu Drug composition for treating variety of illness by influence to reticuloendotherial tissue and method of treating maligmant tumor with said composition in treating human

Also Published As

Publication number Publication date
RU2093160C1 (ru) 1997-10-20
BG61250B1 (bg) 1997-04-30
KR100234855B1 (ko) 1999-12-15
CZ281672B6 (cs) 1996-12-11
CZ232692A3 (en) 1993-02-17
SI9200155A (en) 1993-03-31
FI923364A (fi) 1993-01-25
HU207799B (en) 1993-06-28
EP0524633B1 (en) 1999-03-31
PL295352A1 (en) 1993-02-22
US5312629A (en) 1994-05-17
CA2074639A1 (en) 1993-01-25
US5405620A (en) 1995-04-11
DE69228777D1 (de) 1999-05-06
HRP920192B1 (en) 2000-06-30
EP0524633A3 (en) 1993-07-28
ATE178213T1 (de) 1999-04-15
BG96686A (bg) 1993-12-24
PL169684B1 (pl) 1996-08-30
HUT61475A (en) 1993-01-28
RO109505B1 (ro) 1995-03-30
DE69228777T2 (de) 1999-10-21
HU912492D0 (en) 1991-12-30
SK232692A3 (en) 1995-06-07
CA2074639C (en) 1996-01-09
FI923364A0 (fi) 1992-07-24
KR930001915A (ko) 1993-02-22
JP2673852B2 (ja) 1997-11-05
YU48243B (sh) 1997-08-22
JPH06227992A (ja) 1994-08-16
HRP920192A2 (hr) 1994-04-30
YU81092A (sr) 1996-01-09
EP0524633A2 (en) 1993-01-27

Similar Documents

Publication Publication Date Title
SK278944B6 (sk) Farmaceutický prípravok
US20210299168A1 (en) Pharmaceutical-grade ferric organic compounds, uses thereof and methods of making same
US9050316B2 (en) Pharmaceutical-grade ferric organic compounds, uses thereof and methods of making same
EP1931689B1 (en) Pharmaceutical-grade ferric citrate for medical use
US6589567B2 (en) Anti-cancer therapy agent of arsenic hexoxide (As4O6) of a natural chemical substance and its pharmaceutical composition
EP1318804B1 (en) Iron compositions
WO2023109747A1 (zh) 2,4-二羟基苯甲酸在治疗铁过载疾病药品中的应用
WO1999011256A1 (fr) L-threonate ferreux, composition pharmaceutique le contenant et son utilisation pour reduire et traiter l'anemie chez l'homme
US7261906B2 (en) Anti-cancer therapy agent of arsenic hexoxide (As4O6) of a natural chemical substance and its pharmaceutical composition
AU651824B2 (en) Pharmaceutical composition
US20220144872A1 (en) Pharmaceutical-Grade Ferric Organic Compounds, Uses Thereof and Methods of Making Same
CN113425723A (zh) Pim1小分子抑制剂在制备防治强直性脊柱炎产品中的应用
CN101953848B (zh) 治疗癌症的药物及其用途
Lucas et al. The absorption and utilization of iron salts
US6632837B1 (en) Compositions containing a selenium monobromide-oil reaction product and epichlorohydrin and methods of making the same